Significant Association Between Suprarenal Fixation of Endoprostheses and Renal Dysfunction

According to this meta-analysis, soon to be published in Eur. J. Vasc. Endovasc. Surg., endovascular abdominal aortic aneurysm repair prostheses with suprarenal fixation do not alter significantly the glomerular filtration rate at one year from device implantation. However, we should acknowledge that long-term outcomes are still unknown. The literature is inconsistent as regards the definition of renal dysfunction. In consequence, we will have to settle for this meta-analysis and some speculation, both of which result in more questions than answers.

Endovascular infrarenal abdominal aortic aneurysm repair is currently the standard of care. Many devices available in the market offer suprarenal fixation, aimed at improving prosthesis anchoring and preventing migration (a common occurrence when this technique was first introduced). However, we have not really wondered whether this could affect glomerular filtration in the medium and long term.

This work identified 24 studies on the subject and a meta-analysis was used to assess glomerular filtration rate drop at 1 and 5 years from device implantation.


Read also: Constrictive Pericarditis After Pericardiocentesis.


The primary endpoint was a glomerular filtration rate drop >20% at 1 year, a glomerular filtration rate drop >20% at 5 years, or “renal dysfunction” based on the definition used in each publication.

Among all studies considered, 5 reported glomerular filtration reduction >20%; the odds ratio (OR) was 1.53 (9.3% for suprarenal fixation devices versus 7.4% for non-suprarenal-fixation devices). One of these studies reported this event at 5 years with an OR = 1.77 (16.9% with suprarenal fixation vs. 10.3% without suprarenal fixation; p = 0.03).


Read also: Stroke, Migraine and Patent Foramen Ovale Not Necessarily Temporary Associated.


“Renal dysfunction” definitions varied greatly among studies; in consequence, it was not useful as a point of comparison for differences as regards the addressed event.

Conclusion

Endovascular abdominal aortic aneurysm repair prostheses with suprarenal fixation do not seem to alter glomerular filtration rates at one year from the procedure, and long-term results are limited. Unfortunately, arbitrary definitions of renal dysfunction are too common in the literature, thus precluding further conclusions.

Original title: The Impact of Suprarenal Fixation on Renal Function Following Endovascular Abdominal Aortic Aneurysm Repair: Meta-Analysis Based on Estimated Glomerular Filtration Rate.

Reference: T. Calderbank et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...